‘Surprising’ finding by Australian-led study is first recorded instance of one antibiotic causing resistance to another in a different class
The rise of an almost untreatable superbug has been linked to a common antibiotic, an Australian-led study has found.
The study – published in Nature – found that rifaximin, an antibiotic used to treat liver disease, causes resistance to another antibiotic, daptomycin.
Continue reading...